0001209191-21-063235.txt : 20211105
0001209191-21-063235.hdr.sgml : 20211105
20211105172339
ACCESSION NUMBER: 0001209191-21-063235
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211001
FILED AS OF DATE: 20211105
DATE AS OF CHANGE: 20211105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Galante Joseph C
CENTRAL INDEX KEY: 0001632384
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33637
FILM NUMBER: 211385778
MAIL ADDRESS:
STREET 1: 111 TENTH AVENUE
STREET 2: SUITE 200
CITY: NASHVILLE
STATE: TN
ZIP: 37203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001087294
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE,
STATE: TN
ZIP: 37203
BUSINESS PHONE: 615-255-0068
MAIL ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE
STATE: TN
ZIP: 37203
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-10-01
0
0001087294
CUMBERLAND PHARMACEUTICALS INC
CPIX
0001632384
Galante Joseph C
2525 WEST END AVENUE
SUITE 950
NASHVILLE
TN
37203
1
0
0
0
Common Stock
2021-10-01
4
P
0
142
2.69
A
40937
D
Common Stock
2021-10-04
4
P
0
142
2.87
A
41079
D
Common Stock
2021-10-05
4
P
0
142
2.82
A
41221
D
Common Stock
2021-10-06
4
P
0
142
2.76
A
41363
D
Common Stock
2021-10-07
4
P
0
142
2.76
A
41505
D
Common Stock
2021-10-08
4
P
0
142
2.84
A
41647
D
Common Stock
2021-10-11
4
P
0
142
2.73
A
41789
D
Common Stock
2021-10-12
4
P
0
142
2.71
A
41931
D
Common Stock
2021-10-13
4
P
0
142
2.71
A
42073
D
Common Stock
2021-10-14
4
P
0
142
2.81
A
42215
D
Common Stock
2021-10-15
4
P
0
142
2.76
A
42357
D
Common Stock
2021-10-18
4
P
0
142
2.75
A
42499
D
Common Stock
2021-10-19
4
P
0
142
2.76
A
42641
D
Common Stock
2021-10-20
4
P
0
142
2.63
A
42783
D
Common Stock
2021-10-21
4
P
0
142
2.65
A
42925
D
Common Stock
2021-10-22
4
P
0
142
2.66
A
43067
D
Common Stock
2021-10-25
4
P
0
142
2.64
A
43209
D
Common Stock
2021-10-26
4
P
0
142
2.64
A
43351
D
Common Stock
2021-10-27
4
P
0
142
2.61
A
43493
D
Common Stock
2021-10-28
4
P
0
142
2.61
A
43635
D
Common Stock
2021-10-29
4
P
0
142
2.72
A
43777
D
The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
Joseph C. Galante by /s/ John Hamm as
attorney-in-fact
2021-11-05